ANI Pharmaceuticals, Inc. (ANIP)
77.27
+2.05
(+2.73%)
USD |
NASDAQ |
Mar 03, 13:00
ANI Pharmaceuticals Research and Development Expense (Annual) : 51.66M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| CorMedix, Inc. | 3.942M |
| Castle Biosciences, Inc. | 51.50M |
| Arcutis Biotherapeutics, Inc. | 77.05M |
| Allogene Therapeutics, Inc. | 178.66M |
| Amicus Therapeutics, Inc. | 135.84M |